Toxicologists are scientific experts who study the harmful effects of chemicals, substances, and environmental agents on living organisms. Their work is essential in assessing the safety of pharmaceuticals, food additives, industrial chemicals, and cosmetics before these products reach the public. By conducting laboratory experiments, animal studies, and cellular assays, toxicologists determine safe exposure levels and identify potential health risks. They play a critical role in drug development by helping to evaluate toxicity profiles and ensure that new treatments meet safety regulations. Their insights also inform regulatory guidelines and public health policies that protect people from environmental hazards.
Toxicologists are often involved in forensic investigations, environmental assessments, and risk analysis. They collaborate with healthcare professionals, regulatory agencies, and environmental scientists to interpret data and recommend actions in cases of contamination, poisoning, or chemical exposure. Their expertise is particularly valuable in addressing concerns related to pollution, occupational safety, and the long-term health effects of chronic exposure to various substances. With advancements in analytical technology and molecular toxicology, toxicologists can now better understand how toxins interact with genes and cellular processes. Their work forms the foundation for ensuring public safety in an increasingly chemical-dependent world. As new chemicals are introduced into our environment, toxicologists remain essential in safeguarding health and maintaining ecological balance.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia